These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 8235930)
21. Normokalemic hyperaldosteronism in patients with resistant hypertension. Benchetrit S; Bernheim J; Podjarny E Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302 [TBL] [Abstract][Full Text] [Related]
22. Negative association between plasma aldosterone concentration/plasma renin activity and morning blood pressure surge in never-treated hypertensive patients. Cho JS; Ihm SH; Jang SW; Chung WB; Choi YS; Shin DI; Seo SM; Park MW; Kim GH; Her SH; Kim CJ; Kim TH; Kang MK; Chang K; Park CS Clin Exp Hypertens; 2014; 36(4):195-9. PubMed ID: 24678899 [TBL] [Abstract][Full Text] [Related]
24. [Possible pathogenetic role of 11 beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) gene polymorphisms in arterial hypertension]. Morales MA; Carvajal CA; Ortiz E; Mosso LM; Artigas RA; Owen GI; Fardella CE Rev Med Chil; 2008 Jun; 136(6):701-10. PubMed ID: 18769825 [TBL] [Abstract][Full Text] [Related]
25. [Arterial hypertension in patients on chronic hemodialysis]. Zogović J; Mladenović Lj Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857 [TBL] [Abstract][Full Text] [Related]
26. Low plasma renin activity and high aldosterone/renin ratio are associated with untreated isolated systolic hypertension. Durukan M; Guray U; Aksu T; Guray Y; Demirkan B; Korkmaz S Blood Press; 2012 Oct; 21(5):320-5. PubMed ID: 22587638 [TBL] [Abstract][Full Text] [Related]
27. Renin-angiotensin-aldosterone system, RR interval, and blood pressure variability during postural changes in borderline arterial hypertension. Duprez DA; De Sutter JH; De Buyzere ML; Rietzschel ER; Rimbaut S; Kaufman JM; Van Hoecke MJ; Clement DL Am J Hypertens; 1995 Jul; 8(7):683-8. PubMed ID: 7546493 [TBL] [Abstract][Full Text] [Related]
28. [The importance of studying the renin-angiotensin-aldosterone system in essential arterial hypertension in clinical practice. Activity of the renin-angiotensin-aldosterone system during treatment of hypertension with ACE-inhibitors and beta blockers]. Hrnciar J; Hrnciarová M; Lepej J; Okálová D; Kreze A; Chamulová M Vnitr Lek; 1994 Sep; 40(9):557-62. PubMed ID: 7975357 [TBL] [Abstract][Full Text] [Related]
29. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration. Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166 [TBL] [Abstract][Full Text] [Related]
33. [Effects of slow-release nicardipine on blood pressure, renal function and the renin-angiotensin-aldosterone system in patients with mild-to-moderate essential arterial hypertension]. Melina D; Guerrera G; Santoliquido A; Colivicchi F; Melina G; Musumeci V; Guerrera C Clin Ter; 1991 Nov 15-30; 139(3-4):101-6. PubMed ID: 1837249 [TBL] [Abstract][Full Text] [Related]
34. [Changes of the renin-angiotensin-aldosterone system and immunologic parameters in essential and symptomatic arterial hypertension]. Shulutko BI; Baliasnikova TN Klin Med (Mosk); 1993; 71(6):24-7. PubMed ID: 8145496 [TBL] [Abstract][Full Text] [Related]
35. [The renin-angiotensin-aldosterone system and arterial hypertension in patients with rheumatoid arthritis]. Samoriadova OS; Zharova EA; Masenko VP; Balabanova RM; Vil'chinskaia MIu; Nasonov EL Klin Med (Mosk); 1991 Feb; 69(2):69-71. PubMed ID: 1875668 [TBL] [Abstract][Full Text] [Related]
36. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. van den Born BJ; Koopmans RP; van Montfrans GA Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041 [TBL] [Abstract][Full Text] [Related]
37. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders. Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163 [TBL] [Abstract][Full Text] [Related]
38. Hypertension and depressed symptomatology: a cluster related to the activation of the renin-angiotensin-aldosterone system (RAAS). Findings from population based KORA F4 study. Häfner S; Baumert J; Emeny RT; Lacruz ME; Bidlingmaier M; Reincke M; Ladwig KH Psychoneuroendocrinology; 2013 Oct; 38(10):2065-74. PubMed ID: 23608138 [TBL] [Abstract][Full Text] [Related]
39. The renin-angiotensin-aldosterone system in primary and secondary hypertension. del Greco F; Huang CM; Quintanilla A; Krumlovsky F; Roxe DM; Santhanam S Ann Clin Lab Sci; 1981; 11(6):497-505. PubMed ID: 6119955 [TBL] [Abstract][Full Text] [Related]
40. [Hormonal mechanisms in the regulation of arterial pressure and its hemodynamic structure in old age]. Tokar' AV; Ena LM; Magdich LV Fiziol Zh (1978); 1990; 36(5):111-6. PubMed ID: 2176988 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]